
Dr. Ernest Beutler
(Sep. 30, 1928 – Oct. 5, 2008)

Dr. Ernest Beutler, who first identified the G6PD enzyme deficiency in 1953, the man who was most instrumental in establishing this Web site back in 1996, a giant among scientists and a most generous, gracious person, passed away on October 5. See obituaries in The Los Angeles Times and The New York Times. A more detailed biography on Wikipedia. To read some of his articles, turn to our list of Research Papers.
|
|
 |

LOW-RISK DRUGS FOR G6PD DEFICIENTS
|
 |
|
Low-risk drugs which can probably be given
in NORMAL THERAPEUTIC DOSES to G-6-PD-deficient subjects without nonspherocytic hemolytic anemia
By Ernest Beutler, M.D. (see complete article here)
[Most important phrase to note here is "in normal therapeutic doses." Some of the listed drugs appear also in our To Avoid List under "low risk."]
- Acetaminophen (paracetamol, Tylenol, Tralgon, hydroxyacetanilide)
- Acetophenetidin (phenacetin)
- Aminopyrine (Pyramidon, amidopyrine)
- Antazoline (Antistine)
- Antipyrine
- Ascorbic acid (vitamin C)
- Benzhexol (Artane)
- Chloramphenicol [high risk for Mediterranean and Asian variants]
- Chlorguanidine (Proguanil, Paludrine)
- Chloroquine
- Colchicine
- Diphenhydramine (Benadryl)
- Isoniazid
- L-Dopa
- Menadione sodium bisulfite (Hykinone)
- Menapthone
- p-Aminobenzoic acid
- Phenylbutazone
- Phenytoin
- Probenecid (Benemid)
- Procain amide hydrochlonde (Pronestyl)
- Pyrimethamine (Daraprim)
- Quinidine
- Quinine
- Streptomycin
- Sulfacytine
- Sulfadiazine
- Sulfaguanidine
- Sulfamerazine
- Sulfamethoxypyridazine (Kynex)
- Sulfisoxazole (Gantrisin)
- Trimethoprim
- Tripelennamine (pyribenzamine)
- Vitamin K
See also R&D Diagnostics Ltd: Updated list with trade names (purchase also test kit).
|
|